Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis

2017/01/13 by Di Song, Wei-yi Guo, Weiyi Guo +8 · 25 citations
Immunology and Microbiology · Medicine · #Complement system in diseases #Systemic Lupus Erythematosus Research #Xenotransplantation and immune response

paper · doi:10.1016/j.amjms.2017.01.005

Citations

• Derivation of the sledai. A disease activity index for lupus patients
• Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus

Cited by

• Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus. [europepmc]
• Clinical significance of C4d deposition in renal tissues from patients with primary Sjögren's syndrome-a preliminary study. [europepmc]
• Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis. [europepmc]
• Complement and Complement Targeting Therapies in Glomerular Diseases. [europepmc]
• A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies. [europepmc]
• The Complement C3a and C3a Receptor Pathway in Kidney Diseases. [europepmc]
• Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. [europepmc]
• Glomerular Complement Factor H-Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy. [europepmc]
• Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys. [europepmc]
• An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases. [europepmc]
• Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis. [europepmc]
• Intertwined pathways of complement activation command the pathogenesis of lupus nephritis. [europepmc]
• Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis. [europepmc]
• Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy. [europepmc]
• The complement system in pediatric acute kidney injury. [europepmc]
• Kidney diseases. [europepmc]
• Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis. [europepmc]
• Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis. [europepmc]
• Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies. [europepmc]
• Complement as a Biomarker for Systemic Lupus Erythematosus. [europepmc]
• Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. [europepmc]
• Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China. [europepmc]
• Management of Lupus Nephritis: New Treatments and Updated Guidelines. [europepmc]
• Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. [europepmc]
• Urinary complement biomarkers in immune-mediated kidney diseases. [europepmc]